Search Within

Samuel Aaron Funt

Formats
  1. Meeting Abstract (72)
  2. Journal Article (62)
  3. Review (3)
  4. Correspondence (2)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (141)
  2. Genitourinary Oncology Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Weinberg Fellows (141)
  5. Department of Pathology and Laboratory Medicine (74)
  6. Surgery (62)

More Groups

People
  1. Dean Bajorin (90)
  2. Jonathan Rosenberg (75)
  3. Gopakumar Iyer (66)
  4. Hikmat Al-Ahmadie (54)
  5. Darren Feldman (49)
  6. Min Yuen Teo (47)

More People

Years
  1. 2025 (8)
  2. 2024 (19)
  3. 2023 (13)
  4. 2022 (19)
  5. 2021 (19)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Annals of Oncology (4)
  3. Clinical Cancer Research (4)
  4. European Urology (3)
  5. JCO Precision Oncology (3)
  6. Nature Communications (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Elsevier Science, Inc. (9)
  3. Nature Publishing Group (7)
  4. American Association for Cancer Research (6)
  5. Elsevier Inc. (6)
  6. Oxford University Press (5)

More Publishers

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors
    Journal Article

    Matulewicz, R. S.; Assel, M.; Vickers, A. J.; Jayalath, V. H.; Gold, S. A.; Funt, S. A.; Feldman, D. R.; Sheinfeld, J.
    Journal of Urology (2025)

    Fulltext@MSK | Save
  • Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours
    Research Letter

    Gold, S. A.; Yu, R.; Jayalath, V. H.; Baky, F.; Liso, N.; Williams, B.; Tin, A. L.; Feldman, D. R.; Funt, S. A.; Vickers, A. J.; more...
    BJU International (2025)

    Fulltext@MSK | Save
  • Cutaneous toxicity and clinical outcomes with enfortumab vedotin and pembrolizumab in patients with locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Arbuiso, A.; Sternschuss, M.; Whiting, K.; Gupta, A.; Huttenlocher Bent, E.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Arbuiso, A.; Gupta, A.; Bent, E. H.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Quality of informed consent via telemedicine compared with in-person for clinical cancer research
    Journal Article

    Sternschuss, M.; Lattanzi, M.; Vertosick, E.; Austria, M.; Martin, S.; Regazzi, A.; Buckely, M. T.; Lengfellner, J.; Riely, G. J.; Solit, D. B.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
    Journal Article

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
    Journal Article

    Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
    Meeting Abstract

    Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Stereotactic radiosurgery and whole brain radiotherapy for germ cell tumor brain metastases: Practice patterns and outcomes
    Meeting Abstract

    Gui, C.; Funt, S.; Boe, L. A.; Yu, Y.; Zinovoy, M.; Chen, L.; Yamada, Y.; Pike, L. R. G.; Feldman, D.; Imber, B. S.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save